Product Code Database
Hemantane, or hymantane, also known as N-(2-adamantyl)hexamethyleneimine, is an experimental antiparkinsonian agent of the adamantane family that was never marketed. It was developed and studied in Russia.
It has been said to act as a low-affinity non-competitive NMDA receptor antagonist, as a selective MAO-B inhibitor, and as showing various other actions and effects such as modulation of the dopaminergic and serotonergic systems in the striatum. The drug has also been theorized to be a sigma receptor agonist, which is said to likely be involved in its dopaminergic effects. Analogues of hemantane, such as memantine and amantadine, share some of these actions, like NMDA receptor antagonism, sigma receptor agonism, and dopaminergic modulation.
The drug was first described by 2000.
The dosage of gimantan is standardized to 50mg tablet strength.
|
|
